Asston Pharmaceu

{
  "main_header": {
    "sid": 10039662,
    "name": "Asston Pharmaceu",
    "stock_name": "Asston Pharmaceu",
    "full_name": "Asston Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/asston-pharmaceu",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "69.00",
    "chg": -1,
    "chgp": "-1.43%",
    "dir": -1,
    "prev_price": "70.00",
    "mcapval": "60.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544445,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0SJX01015",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": 23000,
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/asston-pharmaceu-10039662-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 6,
    "sid": "10039662",
    "stock_news_url": "https://www.marketsmojo.com/news/asston-pharmaceuticals-10039662"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Scheduled To Be Held On 30Th March 2026 At 3:00 P.M. At The Registered Office Of The Company",
      "datetime": "25-Mar-2026",
      "details": "Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 inter alia to consider and approve 1. To consider the appointment of Mr. Sumit Pawar as Chief Financial Officer of the Company. 2. To consider the appointment of Mr. Yashvardhan Tupe as Additional Non-Executive Director of the Company. 3. To consider the appointment of Mr. Sandip Sharma as Additional Non-Executive Independent Director of the Company. 4. To take note of the circular resolution passed by the Company for the appointment of a statutory auditor of the Company. 5. To consider and approve the date and Notice of the Extraordinary General Meeting of the Company. 6. Other incidental Matters",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
      "datetime": "02-Mar-2026",
      "details": "Appointment of M/s Panchal S K and Associates as the Statutory Auditor of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "02-Mar-2026",
      "details": "Appointment of M/s Panchal S K and Associates as the Statutory Auditor of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "30 Mar 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News